These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 18256353)

  • 1. The role of inflammatory cytokines in diabetic nephropathy.
    Navarro-González JF; Mora-Fernández C
    J Am Soc Nephrol; 2008 Mar; 19(3):433-42. PubMed ID: 18256353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor-alpha as a therapeutic target for diabetic nephropathy.
    Navarro-González JF; Jarque A; Muros M; Mora C; García J
    Cytokine Growth Factor Rev; 2009 Apr; 20(2):165-73. PubMed ID: 19251467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic perspectives for the role of inflammation in diabetic nephropathy.
    Rivero A; Mora C; Muros M; García J; Herrera H; Navarro-González JF
    Clin Sci (Lond); 2009 Mar; 116(6):479-92. PubMed ID: 19200057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of TNF-alpha in diabetic nephropathy: pathogenic and therapeutic implications.
    Navarro JF; Mora-Fernández C
    Cytokine Growth Factor Rev; 2006 Dec; 17(6):441-50. PubMed ID: 17113815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of diabetic nephropathy in type 2 DM: candidate gene analysis for the pathogenic role of inflammation.
    Lee SH; Lee TW; Ihm CG; Kim MJ; Woo JT; Chung JH
    Nephrology (Carlton); 2005 Oct; 10 Suppl():S32-6. PubMed ID: 16174285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy.
    Elmarakby AA; Sullivan JC
    Cardiovasc Ther; 2012 Feb; 30(1):49-59. PubMed ID: 20718759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advancement of understanding pathogenesis of type 1 diabetes and potential relevance to diabetic nephropathy.
    Ichinose K; Kawasaki E; Eguchi K
    Am J Nephrol; 2007; 27(6):554-64. PubMed ID: 17823503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transcriptomics illustrate a deadly TRAIL to diabetic nephropathy].
    Benito-Martín A; Ucero AC; Santamaría B; Lorz C; Kretzler M; Rastaldi MP; Sánchez-Niño MD; Sanz A; Izquierdo MC; Ruiz Ortega M; Egido J; Ortiz A
    Nefrologia; 2009; 29(1):13-9. PubMed ID: 19240767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokines in diabetic nephropathy.
    Wu CC; Sytwu HK; Lin YF
    Adv Clin Chem; 2012; 56():55-74. PubMed ID: 22397028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephropathy in type 1 diabetes.
    Marre M
    Semin Vasc Med; 2002 Feb; 2(1):97-107. PubMed ID: 16222600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do inflammatory cytokine genes confer susceptibility to diabetic nephropathy?
    Maeda S
    Kidney Int; 2008 Aug; 74(4):413-5. PubMed ID: 18670406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory process in type 2 diabetes: The role of cytokines.
    Alexandraki K; Piperi C; Kalofoutis C; Singh J; Alaveras A; Kalofoutis A
    Ann N Y Acad Sci; 2006 Nov; 1084():89-117. PubMed ID: 17151295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes, inflammation, proinflammatory cytokines, and diabetic nephropathy.
    Navarro JF; Mora C
    ScientificWorldJournal; 2006 Aug; 6():908-17. PubMed ID: 16906324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation and the pathogenesis of diabetic nephropathy.
    Wada J; Makino H
    Clin Sci (Lond); 2013 Feb; 124(3):139-52. PubMed ID: 23075333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diabetic nephropathy and prevention of diabetic nephropathy caused chronic renal insufficiency].
    Jakić M; Jakić M; Zibar L; Mihaljević D; Stipanić S; Teskera T
    Lijec Vjesn; 2009; 131(7-8):218-25. PubMed ID: 19769285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of diabetic nephropathy: involvement of multifaceted signalling mechanism.
    Balakumar P; Arora MK; Reddy J; Anand-Srivastava MB
    J Cardiovasc Pharmacol; 2009 Aug; 54(2):129-38. PubMed ID: 19528810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation and diabetic nephropathy.
    Mora C; Navarro JF
    Curr Diab Rep; 2006 Dec; 6(6):463-8. PubMed ID: 17118230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of IL-18 in type 1 diabetic nephropathy: The problem and future treatment.
    Elsherbiny NM; Al-Gayyar MM
    Cytokine; 2016 May; 81():15-22. PubMed ID: 26836949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats.
    Ko GJ; Kang YS; Han SY; Lee MH; Song HK; Han KH; Kim HK; Han JY; Cha DR
    Nephrol Dial Transplant; 2008 Sep; 23(9):2750-60. PubMed ID: 18388116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial dysfunction: a tug of war in diabetic nephropathy?
    Balakumar P; Chakkarwar VA; Krishan P; Singh M
    Biomed Pharmacother; 2009 Mar; 63(3):171-9. PubMed ID: 18823739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.